IL6 and serum lipopolysaccharide activity: Furthermore, in a rat model of endotoxemia, both compounds reduced TNF-α and IL-6 levels by decreasing NF-κB expression in the lung and liver, in addition to counteracting histopathological changes caused by LPS.